These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18490853)

  • 1. Pharmacogenomics of cardiovascular pharmacology: pharmacogenomic network of cardiovascular disease models.
    Tanaka T; Oka T; Shimada Y; Umemoto N; Kuroyanagi J; Sakamoto C; Zang L; Wang Z; Nishimura Y
    J Pharmacol Sci; 2008 May; 107(1):8-14. PubMed ID: 18490853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics and therapeutic target validation in cerebral vasospasm.
    Tanaka T; Nishimura Y; Tsunoda H; Naka M
    J Cardiovasc Pharmacol; 2000; 36 Suppl 2():S1-4. PubMed ID: 11206713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role for heat shock protein 72 in antagonizing cerebral vasospasm after rat subarachnoid hemorrhage.
    Nikaido H; Tsunoda H; Nishimura Y; Kirino T; Tanaka T
    Circulation; 2004 Sep; 110(13):1839-46. PubMed ID: 15381648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacogenomics and pharmainformatics].
    Tanaka T; Nishimura Y; Tsunoda H; Kitaoka Y; Naka M
    Nihon Rinsho; 2002 Jan; 60(1):39-50. PubMed ID: 11808338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heme oxygenase-1 gene induction as an intrinsic regulation against delayed cerebral vasospasm in rats.
    Suzuki H; Kanamaru K; Tsunoda H; Inada H; Kuroki M; Sun H; Waga S; Tanaka T
    J Clin Invest; 1999 Jul; 104(1):59-66. PubMed ID: 10393699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic induction of heme oxygenase-1 by nicaraven after subarachnoid hemorrhage to prevent delayed cerebral vasospasm.
    Shimada Y; Tsunoda H; Zang L; Hirano M; Oka T; Tanaka T
    Eur J Pharmacol; 2009 Oct; 620(1-3):16-20. PubMed ID: 19686725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Heme oxgenase-1 gene induction and the mechanism in the rat vasospasm model].
    Tsunoda H; Suzuki H; Kanamaru K; Tanaka T
    Nihon Yakurigaku Zasshi; 1999 Oct; 114 Suppl 1():55P-59P. PubMed ID: 10629855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heme oxygenase-1 gene therapy for prevention of vasospasm in rats.
    Ono S; Komuro T; Macdonald RL
    J Neurosurg; 2002 Jun; 96(6):1094-102. PubMed ID: 12066912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenomics of cardiovascular pharmacology: development of an informatics system for analysis of DNA microarray data with a focus on lipid metabolism.
    Takahara Y; Kobayashi T; Takemoto K; Adachi T; Osaki K; Kawahara K; Tsujimoto G
    J Pharmacol Sci; 2008 May; 107(1):1-7. PubMed ID: 18490852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of experimental cerebral vasospasm by protein transduction of heme oxygenase 1 (HO-1) conjugated to a residue of 11 arginines.
    Ogawa T; Hänggi D; Steiger HJ
    Acta Neurochir Suppl; 2011; 112():111-3. PubMed ID: 21691998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-expression/co-location of S100 proteins (S100B, S100A1 and S100A2) and protein kinase C (PKC-beta, -eta and -zeta) in a rat model of cerebral basilar artery vasospasm.
    Lefranc F; Decaestecker C; Brotchi J; Heizmann CW; Dewitte O; Kiss R; Mijatovic T
    Neuropathol Appl Neurobiol; 2005 Dec; 31(6):649-60. PubMed ID: 16281914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heme oxygenase-1 and the vascular bed: from molecular mechanisms to therapeutic opportunities.
    Loboda A; Jazwa A; Grochot-Przeczek A; Rutkowski AJ; Cisowski J; Agarwal A; Jozkowicz A; Dulak J
    Antioxid Redox Signal; 2008 Oct; 10(10):1767-812. PubMed ID: 18576916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomics to Revive Drug Development in Cardiovascular Disease.
    Dubé MP; de Denus S; Tardif JC
    Cardiovasc Drugs Ther; 2016 Feb; 30(1):59-64. PubMed ID: 26768480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracranial heme metabolism and cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
    Suzuki H; Muramatsu M; Kojima T; Taki W
    Stroke; 2003 Dec; 34(12):2796-800. PubMed ID: 14657544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the monocyte/macrophage system in heart failure by targeting heme oxygenase-1.
    Tomczyk M; Kraszewska I; Dulak J; Jazwa-Kusior A
    Vascul Pharmacol; 2019 Jan; 112():79-90. PubMed ID: 30213580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomic Challenges in Cardiovascular Diseases: Examples of Drugs and Considerations for Future Integration in Clinical Practice.
    Chatelin J; Stathopoulou MG; Arguinano AA; Xie T; Visvikis-Siest S
    Curr Pharm Biotechnol; 2017; 18(3):231-241. PubMed ID: 28117005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting heme oxygenase: therapeutic implications for diseases of the cardiovascular system.
    Peterson SJ; Frishman WH; Abraham NG
    Cardiol Rev; 2009; 17(3):99-111. PubMed ID: 19384082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of Hypoxia-Inducible Heme Oxygenase-1 Gene for Site-Specific Gene Therapy in the Ischemic Stroke Animal Model.
    Choi M; Oh J; Rhim T; Lee M
    Pharm Res; 2016 Sep; 33(9):2250-8. PubMed ID: 27324961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CGS 26303 upregulates mRNA expression of heme oxygenase-1 in brain tissue of rats subjected to experimental subarachnoid hemorrhage.
    Yen CP; Chen SC; Lin TK; Wu SC; Chang CY; Lue SI; Jeng AY; Kassell NF; Kwan AL
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S474-8. PubMed ID: 15838352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target validation in hypoxia-induced vascular remodeling using transcriptome/metabolome analysis.
    Amano H; Maruyama K; Naka M; Tanaka T
    Pharmacogenomics J; 2003; 3(3):183-8. PubMed ID: 12815367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.